The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 16, 2023

Filed:

Oct. 23, 2015
Applicants:

Memorial Sloan-kettering Cancer Center, New York, NY (US);

Cornell University, Ithaca, NY (US);

Inventors:

Lorenz Studer, New York, NY (US);

Asif M. Maroof, Bowie, MA (US);

Stewart Anderson, Philadelphia, PA (US);

Assignees:

MEMORIAL SLOAN-KETTERING CANCER CENTER, New York, NY (US);

CORNELL UNIVERSITY, Ithaca, NY (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 5/0793 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0619 (2013.01); G01N 33/5029 (2013.01); G01N 33/5058 (2013.01); G01N 33/5073 (2013.01); G01N 33/5088 (2013.01); C12N 2501/15 (2013.01); C12N 2501/41 (2013.01); C12N 2501/415 (2013.01); C12N 2501/999 (2013.01); C12N 2502/08 (2013.01); C12N 2506/02 (2013.01);
Abstract

Provided are cortical interneurons and other neuronal cells and in vitro methods for producing such cortical interneurons and other neuronal cells by the directed differentiation of stem cells and neuronal progenitor cells. The present disclosure relates to novel methods of in vitro differentiation of stem cells and neural progenitor cells to produce several type neuronal cells and their precursor cells, including cortical interneurons, hypothalamic neurons and pre-optic cholinergic neurons. The present disclose describes the derivation of these cells via inhibiting SMAD and Wnt signaling pathways and activating SHH signaling pathway. The present disclosure relates to the novel discovery that the timing and duration of SHH activation can be harnessed to direct controlled differentiation of neural progenitor cells into either cortical interneurons, hypothalamic neurons or pre-optic cholinergic neurons. The present disclosure also relates to compositions of cortical interneurons, hypothalamic neurons or pre-optic cholinergic neurons, and their precursors, that are highly enriched and can be used in variety of application. These cells can be used therapeutically to treat neurodegenerative and neuropsychiatric disorders, and can be used for disease modeling and drug screening.


Find Patent Forward Citations

Loading…